InspectifAI

InspectifAI is a spin-off of the Körber Group, founded in 2021, with a mission to improve drug and patient safety through the scalable usage and deployment of artificial intelligence in visual inspection. As a joint venture of the Digital and Pharma business areas, the company combines regulatory expertise, visual inspection, and validation know-how with data science, software development, and design competencies. The company believes in the power of data to radically redesign and optimize visual inspection in the pharmaceutical industry. InspectifAI provides a machine-agnostic software solution to improve detection accuracy, minimize false-eject-rates, monitor inspection results, and enable the machine-agnostic transfer of AI-models. They accompany their customers from initial consulting to final validation, leveraging their significant experience in Pharma and understanding the needs and requirements of the pharmaceutical industry. Based in Germany, InspectifAI aims to leverage insights and learnings among diverse machine platforms, creating synergy, network, and scaling effects to make the best use of AI for visual inspection. The company is poised to make a significant impact, bridging the gap between traditional visual inspection and cutting-edge AI technology in the pharmaceutical industry.